...
首页> 外文期刊>Current Pollution Reports >Treatment of nonocclusive mesenteric ischemia with type B aortic dissection using intra-arterial catheterization after trauma surgery: case report
【24h】

Treatment of nonocclusive mesenteric ischemia with type B aortic dissection using intra-arterial catheterization after trauma surgery: case report

机译:在创伤手术后使用动脉内导尿管的B型主动脉夹层的非瘢痕式肠系膜缺血治疗:案例报告

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AbstractBackgroundNonocclusive mesenteric ischemia (NOMI) is a mesenteric arterial spasm and intestinal ischemia. This disease is a highly lethal disease because diagnosis and decision of appropriate treatments are often difficult. Operations cannot resolve the spasms and may worsen the situation. However, the safety and effectiveness of catheterization for NOMI with aortic dissection (AD) have not yet been elucidated. Here, we report a successful case of early diagnosis and treatment of NOMI with type B AD involving the superior mesenteric artery (SMA) using the intra-arterial infusion of a vasodilator via the SMA.Case presentationAn 83-year-old man was admitted to our hospital because of abdominal pain after a motor accident. We performed intestinal resection and splenectomy for intestinal perforation and splenic hemorrhage and treated conservatively for acute AD, liver injury, renal hematoma, and pneumothorax. On postoperative day (POD) 2, the patient had localized abdominal pain. Follow-up computed tomography suggested a smaller superior mesenteric vein sign and segmental lack of enhancement in the intestinal wall and ascites without SMA occlusion. Thus, the patient was diagnosed with NOMI. Although the patient had type B AD including the SMA, we performed selective mesenteric arteriography and transcatheter papaverine infusion via the SMA and prostaglandin via the peripheral vein. Seven days post treatment, mesenteric blood flow improved and intestinal wall enhancement was restored.ConclusionThe intra-arterial infusion of a vasodilator is highly efficient and safety treatment option for NOMI with type B AD. Prompt and accurate management can prevent massive small bowel resection, and this procedure is essential in resolving a spasm independent of whether a necrotic bowel has been resected.]]>
机译:<![cdata [ <标题>抽象 <标题>背景 ara id =“PAR1”>非晶体肠系膜缺血(Nomi)是肠系膜痉挛和肠缺血。这种疾病是一种高度致命的疾病,因为适当治疗的诊断和决定通常很困难。操作无法解决痉挛,可能会恶化。然而,尚未阐明具有主动脉夹层(AD)的NOMI的导尿率的安全性和有效性。在这里,我们向使用SMA血管扩张器的动脉内输注患者患有型肠化学动脉(SMA)的B型AD的早期诊断和治疗NOMI的成功案例。 <标题>案例演示 ara id =“par2”>一个83岁的男子因胃肠疼痛后被院内入院,因为胃肠疼痛。我们对肠穿孔和脾脏出血进行了肠切除和脾切除,并保守治疗急性AD,肝损伤,肾血肿和气胸。在术后一天(POD)2,患者具有局部腹痛。随访的计算机断层扫描表明较小的肠系膜静脉标志,在肠壁和腹水中的节段缺乏增强,没有SMA闭塞。因此,患者被诊断为NOMI。虽然患者患者B型AD,包括SMA,但我们通过外周静脉通过SMA和前列腺素进行选择性肠系膜动脉造影和经膜状蛋白酶输注。治疗后七天,肠系膜血流改善和肠壁增强恢复。 <标题>结论 ara id =“par3”> intra - 血管扩张器的抑制器是具有B型AD型NOMI的高效和安全处理选项。提示和准确的管理可以防止巨大的小肠切除切除,并且该程序对于解决痉挛方案而独立于坏死的肠道已被切除。 ]]>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号